← Eichor
Condition: Active Rheumatoid Arthritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Active Rheumatoid Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
NA · 1 location(s) · Saglik Bilimleri Universitesi · NCT07320846Dose Response of Exercise for Arthritis Management
NA · 1 location(s) · University of South Carolina · NCT06880653Clinical Outcomes Study of the Nexel Total Elbow
NA · 11 location(s) · Zimmer Biomet · NCT02469662Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
NA · 5 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06301373Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 · 28 location(s) · Vor Biopharma · NCT07404865Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severel
Phase 2 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07423533Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)
Phase 4 · 1 location(s) · Universita di Verona · NCT06527534A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Phase 1 · 7 location(s) · Sanofi · NCT06647069Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Phase 1 · 9 location(s) · Sonoma Biotherapeutics, Inc. · NCT06201416Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis
NA · 1 location(s) · Wuerzburg University Hospital · NCT06492200The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07001956A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Phase 2 · 104 location(s) · AbbVie · NCT06972446Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07347860Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Phase 1 · 7 location(s) · Lifordi Immunotherapeutics, Inc. · NCT07207954Korean Post-marketing Surveillance for Xeljanz XR
Phase N/A · 1 location(s) · Pfizer · NCT04876781A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Phase 2 · 57 location(s) · Amgen · NCT06570798A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients
Phase 2 · 30 location(s) · Elevara Medicines Limited · NCT07409103REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
Phase 4 · 7 location(s) · Sint Maartenskliniek · NCT07160231Predictive Utility of a Short-term Improvement in Objectively Measured Physical Activity in Rheumatoid Arthritis (PUSIPA
Phase N/A · 1 location(s) · Esbjerg Hospital - University Hospital of Southern Denmark · NCT06289114Statins and ARBs on Rheumatoid Activity
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03770702A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Phase 1 · 11 location(s) · Cullinan Therapeutics Inc. · NCT07041099Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis
NA · 1 location(s) · Hasan Kalyoncu University · NCT07646262L-carnitine Supplementation in Rheumatoid Arthritis Patients
Phase 2 · 1 location(s) · German University in Cairo · NCT06753565COMFI - a COMbined Fatigue Intervention
NA · 2 location(s) · The Danish Center for Expertise in Rheumatology · NCT06666452Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Phase N/A · 8 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT03003572A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumati
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT06671054Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07062523MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis
Phase 4 · 1 location(s) · Medical University of Vienna · NCT06649136An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06946199
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.